Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 1
1956 2
1957 1
1958 1
1961 2
1962 2
1963 1
1964 2
1965 3
1966 1
1968 1
1969 1
1971 4
1972 3
1974 1
1976 2
1977 4
1978 2
1979 3
1980 2
1981 2
1982 1
1983 1
1984 2
1986 2
1987 2
1988 2
1990 2
1991 1
1992 1
1993 2
1994 1
1997 1
1998 1
2001 1
2003 1
2004 5
2005 5
2006 5
2007 6
2008 5
2009 3
2010 4
2011 5
2012 10
2013 9
2014 5
2015 5
2016 13
2017 14
2018 10
2019 11
2020 16
2021 18
2022 17
2023 10
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Early Treatment with Pegylated Interferon Lambda for Covid-19.
Reis G, Moreira Silva EAS, Medeiros Silva DC, Thabane L, Campos VHS, Ferreira TS, Santos CVQ, Nogueira AMR, Almeida APFG, Savassi LCM, Figueiredo-Neto AD, Dias ACF, Freire Júnior AM, Bitarães C, Milagres AC, Callegari ED, Simplicio MIC, Ribeiro LB, Oliveira R, Harari O, Wilson LA, Forrest JI, Ruton H, Sprague S, McKay P, Guo CM, Limbrick-Oldfield EH, Kanters S, Guyatt GH, Rayner CR, Kandel C, Biondi MJ, Kozak R, Hansen B, Zahoor MA, Arora P, Hislop C, Choong I, Feld JJ, Mills EJ, Glenn JS; TOGETHER Investigators. Reis G, et al. Among authors: callegari ed. N Engl J Med. 2023 Feb 9;388(6):518-528. doi: 10.1056/NEJMoa2209760. N Engl J Med. 2023. PMID: 36780676 Free PMC article. Clinical Trial.
Effect of Early Treatment with Ivermectin among Patients with Covid-19.
Reis G, Silva EASM, Silva DCM, Thabane L, Milagres AC, Ferreira TS, Dos Santos CVQ, Campos VHS, Nogueira AMR, de Almeida APFG, Callegari ED, Neto ADF, Savassi LCM, Simplicio MIC, Ribeiro LB, Oliveira R, Harari O, Forrest JI, Ruton H, Sprague S, McKay P, Guo CM, Rowland-Yeo K, Guyatt GH, Boulware DR, Rayner CR, Mills EJ; TOGETHER Investigators. Reis G, et al. Among authors: callegari ed. N Engl J Med. 2022 May 5;386(18):1721-1731. doi: 10.1056/NEJMoa2115869. Epub 2022 Mar 30. N Engl J Med. 2022. PMID: 35353979 Free PMC article. Clinical Trial.
The Streptococcus pyogenes Proteome.
Callegari EA, Chaussee MS. Callegari EA, et al. 2022 Jul 22. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. 2nd edition. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2022 Oct 8. Chapter 11. 2022 Jul 22. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. 2nd edition. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2022 Oct 8. Chapter 11. PMID: 36479765 Free Books & Documents. Review. No abstract available.
The Streptococcal Proteome.
Callegari EA, Chaussee MS. Callegari EA, et al. 2016 Feb 10. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016–. 2016 Feb 10. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016–. PMID: 26866219 Free Books & Documents. Review.
Animal Models of Hepatocellular Carcinoma Prevention.
Shankaraiah RC, Gramantieri L, Fornari F, Sabbioni S, Callegari E, Negrini M. Shankaraiah RC, et al. Among authors: callegari e. Cancers (Basel). 2019 Nov 14;11(11):1792. doi: 10.3390/cancers11111792. Cancers (Basel). 2019. PMID: 31739536 Free PMC article. Review.
MicroRNAs in Animal Models of HCC.
Fornari F, Gramantieri L, Callegari E, Shankaraiah RC, Piscaglia F, Negrini M, Giovannini C. Fornari F, et al. Among authors: callegari e. Cancers (Basel). 2019 Dec 1;11(12):1906. doi: 10.3390/cancers11121906. Cancers (Basel). 2019. PMID: 31805631 Free PMC article. Review.
MicroRNA response to environmental mutagens in liver.
Elamin BK, Callegari E, Gramantieri L, Sabbioni S, Negrini M. Elamin BK, et al. Among authors: callegari e. Mutat Res. 2011 Dec 1;717(1-2):67-76. doi: 10.1016/j.mrfmmm.2011.03.015. Epub 2011 Apr 14. Mutat Res. 2011. PMID: 21514310 Review.
MicroRNA involvement in hepatocellular carcinoma.
Gramantieri L, Fornari F, Callegari E, Sabbioni S, Lanza G, Croce CM, Bolondi L, Negrini M. Gramantieri L, et al. Among authors: callegari e. J Cell Mol Med. 2008 Dec;12(6A):2189-204. doi: 10.1111/j.1582-4934.2008.00533.x. J Cell Mol Med. 2008. PMID: 19120703 Free PMC article. Review.
End-to-end application of model-informed drug development for ertugliflozin, a novel sodium-glucose cotransporter 2 inhibitor.
Fediuk DJ, Nucci G, Dawra VK, Callegari E, Zhou S, Musante CJ, Liang Y, Sweeney K, Sahasrabudhe V. Fediuk DJ, et al. Among authors: callegari e. CPT Pharmacometrics Syst Pharmacol. 2021 Jun;10(6):529-542. doi: 10.1002/psp4.12633. Epub 2021 May 15. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 33932126 Free PMC article. Review.
212 results